Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial.
Gallamini A, Rossi A, Patti C, Picardi M, Romano A, Cantonetti M, Oppi S, Viviani S, Bolis S, Trentin L, Gini G, Battistini R, Chauvie S, Sorasio R, Pavoni C, Zanotti R, Cimminiello M, Schiavotto C, Viero P, Mulé A, Fallanca F, Ficola U, Tarella C, Guerra L, Rambaldi A. Gallamini A, et al. Among authors: oppi s. J Clin Oncol. 2020 Nov 20;38(33):3905-3913. doi: 10.1200/JCO.20.00935. Epub 2020 Sep 18. J Clin Oncol. 2020. PMID: 32946355 Clinical Trial.
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma.
La Nasa G, Greco M, Littera R, Oppi S, Celeghini I, Caria R, Lai S, Porcella R, Martino M, Romano A, Di Raimondo F, Gallamini A, Carcassi C, Caocci G. La Nasa G, et al. Among authors: oppi s. J Hematol Oncol. 2016 Mar 16;9:26. doi: 10.1186/s13045-016-0255-4. J Hematol Oncol. 2016. PMID: 26983546 Free PMC article.
Relapsing/refractory HL after autotransplantation: which treatment?
Di Renzo N, Gaudio F, Carlo Stella C, Oppi S, Pelosini M, Sorasio R, Stelitano C, Rigacci L. Di Renzo N, et al. Among authors: oppi s. Acta Biomed. 2020 May 25;91(S-5):30-40. doi: 10.23750/abm.v91iS-5.9912. Acta Biomed. 2020. PMID: 32525132 Free PMC article.
Defibrotide in the COVID-19 coagulopathy: What is the timing?
Macciò A, Madeddu C, Caocci G, Oppi S, La Nasa G. Macciò A, et al. Among authors: oppi s. J Thromb Haemost. 2020 Nov;18(11):3113-3115. doi: 10.1111/jth.15100. J Thromb Haemost. 2020. PMID: 32945111 Free PMC article. No abstract available.
Unrelated bone marrow transplantation in thalassemia. The experience of the Italian Bone Marrow Transplant Group (GITMO).
La Nasa G, Giardini C, Locatelli F, Argiolu F, Vassallo E, Prete A, Caocci G, Floris R, Garau P, Littera R, Mantovani D, Oppi S, Piras E, De Stefano P, Sanna MA, Mulargia M, Carcassi C, Contu L; Italian Bone Marrow Transplant Group (GITMO). La Nasa G, et al. Among authors: oppi s. Haematologica. 2002 Aug;87(8 Suppl):58-61. Haematologica. 2002. PMID: 12412392
Defibrotide Has a Role in COVID-19 Therapy.
Macciò A, La Nasa G, Oppi S, Madeddu C. Macciò A, et al. Among authors: oppi s. Chest. 2022 Aug;162(2):271-273. doi: 10.1016/j.chest.2022.04.143. Chest. 2022. PMID: 35940644 Free PMC article. No abstract available.
19 results